Month: June 2021

Implementation of the share capital reduction

Written by Customer Service on June 2, 2021. Posted in Public Companies.

COMPANY ANNOUNCEMENT NO. 28/2021 – 2 JUNE 2021 At Royal Unibrew A/S’ Annual General Meeting on 28 April 2021 a resolution was adopted, following a proposal by the Board of Directors, to reduce the Company’s share capital by a nominal amount of DKK 1,100,000 from nominally DKK 98,700,000 to DKK 97,600,000 by cancelling 550,000 treasury shares of a nominal value of DKK 2 each. The capital reduction has been implemented and registered with the Danish Business Authority today. After the reduction the Company’s share capital is nominally DKK 97,600,000 divided into shares of DKK 2. The revised Articles of Association can be found on the Company’s website www.royalunibrew.com under Investor, Corporate Governance. After the cancellation of treasury shares, the Company’s holding of treasury shares represents 474,120 number of shares (of nominally...

Adyton Resources announces mobilisation at Feni Island; Maiden Copper Gold diamond core drilling program

Written by Customer Service on June 2, 2021. Posted in Public Companies.

Figure 1Feni Project, map showing prospects on magnetics – the drilling program will focus on the Kabang prospect where geophysical targets will be tested (see Fig. 2). Other prospects will be the subject of ongoing exploration.Figure 2Feni DDIP Survey 3D Phase Inversion Model 200m depth slice, with summary interpretation of conductive zone (resistivity < 10 Ωm) superimposed. Proposed drill holes are testing the porphyry copper / gold target to 500m depth (see Figure 3), in addition to testing the shallower epithermal gold zones.Figure 3Perspective view looking to the south-west of the 3D inversion model showing the modelled sub-vertical pipe-like zone porphyry Cu/Au drilling target at Kabang (see Fig 1). As can be seen, the zone is largely untested and extends deeper than the current...

Arch Therapeutics to Present at the LD Micro Invitational XI, June 8 – 10, 2021

Written by Customer Service on June 2, 2021. Posted in Public Companies.

FRAMINGHAM, Mass., June 02, 2021 (GLOBE NEWSWIRE) — Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of novel self-assembling wound care and biosurgical devices, today announced that it will be presented virtually at the upcoming LD Micro Invitational XI event. Chief Executive Officer, Terrence W. Norchi, MD, and Chief Financial Officer, Mike Abrams, are scheduled to present via webcast, which will be available on-demand as of 4:15 PM ET, Thursday, Jun. 10, 2021. You may access & register for the live webcast at https://ldmicrojune2021.mysequire.com/. After the event, the presentation will be available at https://ir.archtherapeutics.com/presentations. About Arch Therapeutics, Inc.Arch Therapeutics, Inc. is a biotechnology company developing a novel approach to stop bleeding (hemostasis), control...

Nicholas Financial Reports 4th Quarter and Fiscal Year 2021 Results

Written by Customer Service on June 2, 2021. Posted in Earnings Releases And Operating Results.

Income year-over-year before income taxes for the three months ended March 31, 2021 increased by 399.6% compared to prior year fourth quarter Pre-tax yield as a percentage of average finance receivables for the three months ended March 31, 2021 increased to 4.92% compared to 1.03% during the prior year fourth quarter Net Portfolio Yield for the three months ended March 31, 2021 increased to 24.22% compared to 17.10% during the prior year fourth quarter Contracts purchased year-over-year for the three months ended March 31, 2021 increased by 25.3% compared to prior year fourth quarter Amount financed year-over-year on Direct Loans for the three months ended March 31, 2021 increased by 5.8% compared to prior year fourth quarter Accounts 60+ days delinquent decreased to 1.9%, excluding Chapter 13 bankruptcy accounts, compared to 2.9% as...

Laurentian Bank Financial Group reports second quarter 2021 results

Written by Customer Service on June 2, 2021. Posted in Earnings Releases And Operating Results.

The financial information reported herein is based on the condensed interim consolidated (unaudited) information for the three-month period ended April 30, 2021, and has been prepared in accordance with International Financial Reporting standards (IFRS), as issued by the International Accounting Standards Board (IASB). All amounts are denominated in Canadian dollars. The Laurentian Bank of Canada and its entities are collectively referred to as Laurentian Bank Financial Group (the “Group” or the “Bank”) and provide deposit, investment, loan, securities, trust and other products or services.Highlights of second quarter 2021 (compared with second quarter 2020)Adjusted net income(1) of $56.7 million, compared with $11.9 million. Reported net income of $53.1 million, compared with $8.9 million. Adjusted diluted earnings per share(1)...

Royalty Pharma Announces $2.025 Billion Strategic Funding Partnership With MorphoSys

Written by Customer Service on June 2, 2021. Posted in Mergers And Acquisitions.

Royalty Pharma to provide tailored funding solution to enable MorphoSys’ acquisition of Constellation Pharmaceuticals Investment is anchored by royalties on Janssen’s Tremfya Partnership also includes royalties on four development-stage therapies, Development Funding Bonds and an investment in MorphoSys common stock Royalty Pharma to host conference call today, Wednesday, June 2 at 8:45am EDTNEW YORK and PLANEGG, Germany, June 02, 2021 (GLOBE NEWSWIRE) — Royalty Pharma plc (Nasdaq: RPRX) and MorphoSys AG (FSE: MOR; Nasdaq: MOR) today announced a $2.025 billion strategic funding partnership as part of MorphoSys’ $1.7 billion acquisition of Constellation Pharmaceuticals (Nasdaq: CNST). This partnership is expected to fuel the expansion of the combined company’s capabilities to help enable the development and potential approvals...

Laurentian Bank Financial Group declares dividend on its common shares

Written by Customer Service on June 2, 2021. Posted in Dividend Reports And Estimates.

MONTREAL, June 02, 2021 (GLOBE NEWSWIRE) — At its meeting held on June 1, 2021, the Board of Directors of the Laurentian Bank of Canada (TSX: LB) (the “Bank”) declared a regular quarterly dividend of 40 cents per share on the common shares payable on August 1, 2021 to the holders of record at the close of business on July 2, 2021. The above-mentioned dividends are designated as eligible dividends for the purposes of the Income Tax Act (Canada) and any similar provincial and territorial legislation. The above-mentioned shares are eligible shares under the Bank’s Shareholder Dividend Reinvestment and Share Purchase Plan (the “Plan”). Consequently, the holders of such shares may elect to reinvest their dividends in newly issued common shares of the Bank. Such purchases will be made at the applicable investment price as defined in...

Icanic Brands Enters into Definitive Agreement to acquire De Krown Enterprises LLC

Written by Customer Service on June 2, 2021. Posted in Mergers And Acquisitions.

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, June 02, 2021 (GLOBE NEWSWIRE) — Icanic Brands Company, Inc. (CSE: ICAN, OTCQB: ICNAF) (“Icanic Brands” or the “Company”), a multi-state brand operator in California and Nevada, is pleased to announce that it has entered into a share exchange agreement dated June 1, 2021 (the “Definitive Agreement”) among the Company, De Krown Enterprises LLC (“ De Krown ”), and the unitholders of De Krown (the “Unitholders”), pursuant to which the Company will acquire 100% of the issued and outstanding units of membership interest (the “Units”) of De Krown (the “Transaction”). De Krown is a California based leading cannabis manufacturing partner and brand owner and is led by a team of successful and tenured executives from the...

BriaCell Reports 12.0 Months Overall Survival Benefit in Advanced Breast Cancer; 100% Resolution of ‘Eye-Bulging’ Tumor

Written by Customer Service on June 2, 2021. Posted in Public Companies.

12.0 months average overall survival benefit, including 13.4 months in patients with 2+ HLA matches and 12.5 months in patients with Grade I/II tumors(1) Top Responder: 21.4 months survival plus 100% resolution of ‘eye-bulging’ orbital tumor Compares to 7.2-9.8 months survival in historical comparison treatment trials(2)BERKELEY, Calif. and VANCOUVER, British Columbia, June 02, 2021 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V:BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer, today provides an update on the overall survival (OS) data on its previously disclosed advanced breast cancer patients. These women were treated with BriaCell’s lead candidate Bria-IMT™ as monotherapy and also in combination with...

Brookfield Infrastructure Announces Intention to Launch a Superior, Revised Cash and Share Offer Directly to Inter Pipeline Ltd. Shareholders, Valued at $19.75 per share, Closing in Approximately 20 days

Written by Customer Service on June 2, 2021. Posted in Public Companies.

Offer HighlightsAggregate cash and share-based consideration totaling C$19.75 per Inter Pipeline Ltd. (TSX: IPL) (“IPL” or the “Company”) share1, representing a 4.4% premium to the Pembina Pipeline Corporation (“Pembina”) share-based offer valued at C$18.91 per share as of market close on June 1, 2021. Cash component of the Offer represents 74% of the total consideration, compared to zero in the Pembina offer. Brookfield Infrastructure has received all regulatory and anti-trust approvals and can close as early as 10 business days from the filing date of the variation to our Offer. Preserves significant local Canadian jobs compared to IPL’s alternative cost synergy-driven transaction.BROOKFIELD, NEWS, June 02, 2021 (GLOBE NEWSWIRE) — Brookfield Infrastructure Partners L.P. (NYSE: BIP; TSX: BIP.UN), together with its institutional...

Month: June 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals